Home
>
National Drug Code (NDC)
>
Halobetasol Propionate
Halobetasol Propionate - 45802-129-35 - (Halobetasol Propionate)
Drug Information of Halobetasol Propionate
| Product NDC: | 45802-129 |
| Proprietary Name: | Halobetasol Propionate |
| Non Proprietary Name: | Halobetasol Propionate |
| Active Ingredient(s): | .5 mg/g & nbsp; Halobetasol Propionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Halobetasol Propionate
| Product NDC: | 45802-129 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077123 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080804 |
Package Information of Halobetasol Propionate
| Package NDC: | 45802-129-35 |
| Package Description: | 1 TUBE in 1 CARTON (45802-129-35) > 15 g in 1 TUBE |
NDC Information of Halobetasol Propionate
| NDC Code | 45802-129-35 |
| Proprietary Name | Halobetasol Propionate |
| Package Description | 1 TUBE in 1 CARTON (45802-129-35) > 15 g in 1 TUBE |
| Product NDC | 45802-129 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Halobetasol Propionate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20080804 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | HALOBETASOL PROPIONATE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
